Nicolet Bankshares’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.2M | Buy |
6,516
+4,347
| +200% | +$801K | 0.04% | 259 |
|
|
2025
Q4 | $382K | Sell |
2,169
-623
| -22% | -$102K | 0.06% | 172 |
|
|
2025
Q3 | $391K | Buy |
2,792
+2
| +0.1% | +$270 | 0.06% | 171 |
|
|
2025
Q2 | $350K | Buy |
2,790
+974
| +54% | +$121K | 0.06% | 174 |
|
|
2025
Q1 | $249K | Sell |
1,816
-149
| -8% | -$21.3K | 0.05% | 184 |
|
|
2024
Q4 | $300K | Buy |
1,965
+489
| +33% | +$82.5K | 0.07% | 168 |
|
|
2024
Q3 | $286K | Sell |
1,476
-83
| -5% | -$17.4K | 0.07% | 176 |
|
|
2024
Q2 | $361K | Sell |
1,559
-1,535
| -50% | -$334K | 0.09% | 160 |
|
|
2024
Q1 | $667K | Buy |
3,094
+32
| +1% | +$7.49K | 0.16% | 117 |
|
|
2023
Q4 | $792K | Buy |
3,062
+311
| +11% | +$76.4K | 0.21% | 102 |
|
|
2023
Q3 | $707K | Sell |
2,751
-1,310
| -32% | -$350K | 0.22% | 97 |
|
|
2023
Q2 | $765K | Buy |
4,061
+1,530
| +60% | +$455K | 0.22% | 95 |
|
|
2023
Q1 | $350K | Buy |
2,531
+8
| +0.3% | +$2.21K | 0.11% | 139 |
|
|
2022
Q4 | $346K | Buy |
2,523
+1,335
| +112% | +$377K | 0.12% | 137 |
|
|
2022
Q3 | $317K | Buy |
+1,188
| New | +$252K | 0.09% | 136 |
|
|
2021
Q3 | – | Sell |
-888
| Closed | -$307K | – | 207 |
|
|
2021
Q2 | $307K | Sell |
888
-115
| -11% | -$34.8K | 0.08% | 164 |
|
|
2021
Q1 | $281K | Hold |
1,003
| – | – | 0.08% | 165 |
|
|
2020
Q4 | $246K | Sell |
1,003
-25
| -2% | -$6.45K | 0.08% | 166 |
|
|
2020
Q3 | $292K | Hold |
1,028
| – | – | 0.1% | 145 |
|
|
2020
Q2 | $275K | Sell |
1,028
-614
| -37% | -$185K | 0.1% | 145 |
|
|
2020
Q1 | $519K | Sell |
1,642
-23
| -1% | -$6.98K | 0.23% | 80 |
|
|
2019
Q4 | $494K | Sell |
1,665
-44
| -3% | -$12.2K | 0.18% | 103 |
|
|
2019
Q3 | $398K | Sell |
1,709
-16
| -0.9% | -$3.73K | 0.16% | 121 |
|
|
2019
Q2 | $403K | Sell |
1,725
-19
| -1% | -$4.39K | 0.17% | 115 |
|
|
2019
Q1 | $412K | Sell |
1,744
-2
| -0.1% | -$630 | 0.17% | 115 |
|
|
2018
Q4 | $525K | Sell |
1,746
-7
| -0.4% | -$2.23K | 0.25% | 78 |
|
|
2018
Q3 | $619K | Sell |
1,753
-421
| -19% | -$145K | 0.25% | 81 |
|
|
2018
Q2 | $631K | Sell |
2,174
-76
| -3% | -$21.4K | 0.27% | 74 |
|
|
2018
Q1 | $616K | Buy |
2,250
+14
| +0.6% | +$4.35K | 0.26% | 75 |
|
|
2017
Q4 | $712K | Sell |
2,236
-83
| -4% | -$26.6K | 0.31% | 66 |
|
|
2017
Q3 | $726K | Sell |
2,319
-153
| -6% | -$45.3K | 0.32% | 64 |
|
|
2017
Q2 | $671K | Buy |
2,472
+700
| +40% | +$185K | 0.32% | 64 |
|
|
2017
Q1 | $485K | Buy |
1,772
+348
| +24% | +$98.4K | 0.25% | 79 |
|
|
2016
Q4 | $404K | Buy |
1,424
+445
| +45% | +$132K | 0.22% | 87 |
|
|
2016
Q3 | $306K | Sell |
979
-379
| -28% | -$112K | 0.18% | 116 |
|
|
2016
Q2 | $328K | Buy |
1,358
+477
| +54% | +$126K | 0.21% | 95 |
|
|
2016
Q1 | $229K | Buy |
881
+76
| +9% | +$20.1K | 0.16% | 128 |
|
|
2015
Q4 | $220K | Buy |
+805
| New | +$231K | 0.22% | 121 |
|
Other funds holding BIIB
VCM
VPM
Nicolet Bankshares's BIIB Position: Q1 2026 in Review
Nicolet Bankshares increased its Biogen (BIIB) stake by 200% in Q1 2026, buying an estimated $801K and bringing the position to 6,516 shares worth $1.2M. The position accounts for 0.04% of the portfolio, ranked #259.
Nicolet Bankshares first reported a position in BIIB in Q4 2015 and has held it in 38 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Nicolet Bankshares held 6,516 shares of Biogen worth $1.2M as of Q1 2026.
- Nicolet Bankshares bought 4,347 Biogen shares in Q1 2026, an estimated $801K.
- Biogen made up 0.04% of Nicolet Bankshares's portfolio in Q1 2026, its #259 holding.
- Nicolet Bankshares first reported a position in Biogen in Q4 2015 and has held it in 38 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Nicolet Bankshares's 13F filing for Q1 2026, filed 14 May 2026.